PTSD and Anxiety: Key Differences, Overlap, and Evidence-Based Treatment

Quick answer: Post-Traumatic Stress Disorder (PTSD) and anxiety disorders are related but clinically distinct conditions. In 2013, the DSM-5 reclassified PTSD from the Anxiety Disorders chapter into its own "Trauma and Stressor-Related Disorders" chapter, reflecting its unique diagnostic criteria and treatment needs. PTSD requires exposure to actual or threatened death, serious injury, or sexual violence; anxiety disorders do not. PTSD is characterized by intrusive re-experiencing (flashbacks, nightmares), avoidance, negative mood and cognitive changes, and heightened arousal. Anxiety disorders feature excessive worry or fear without trauma-linked re-experiencing. However, roughly 50 percent of people with PTSD also have comorbid anxiety disorders (Kessler, 2005). First-line treatments are trauma-focused psychotherapies: Prolonged Exposure (PE), Cognitive Processing Therapy (CPT), and Eye Movement Desensitization and Reprocessing (EMDR), often combined with SSRIs (sertraline or paroxetine, FDA-approved). Benzodiazepines are avoided because they impair extinction learning and worsen long-term outcomes.

If you are in crisis or having severe symptoms, please contact the 988 Suicide and Crisis Lifeline (call or text 988, US), the Veterans Crisis Line (call 988 and press 1 for veterans), or the Crisis Text Line (text HOME to 741741).

Why PTSD is not classified as an anxiety disorder

The DSM-5 change in 2013

For decades, PTSD was classified in the Anxiety Disorders chapter of psychiatric diagnostic manuals. The DSM-5, published in 2013 by the American Psychiatric Association, moved PTSD and related conditions into a new standalone chapter: "Trauma and Stressor-Related Disorders" (code 309.81 for PTSD).

This was not a mere organizational change. Research demonstrated that PTSD has distinct neurobiological, genetic, and treatment features that set it apart from classic anxiety disorders:

Distinct trauma requirement: PTSD requires exposure to a specific traumatic event (actual or threatened death, serious injury, sexual violence). Anxiety disorders develop without trauma exposure (e.g., generalized worry about health, finances, social judgment).
Distinct neurobiology: PTSD primarily involves altered amygdala reactivity (fear processing), suppressed prefrontal function (emotional regulation), and hyperactive dorsal anterior cingulate (error detection and salience). This neurobiological signature differs from generalized anxiety disorder.
Trauma-specific symptoms: PTSD is driven by unwanted intrusive re-experiencing of the traumatic event (flashbacks, nightmares, sensory memories). Anxiety disorders feature worry and fear but not trauma re-experiencing.
Negative alterations in mood and cognition: PTSD includes symptoms unique to trauma recovery: persistent negative beliefs about the self ("I am a failure," "I cannot be trusted"), blame of self or others, diminished interest in activities, emotional numbing, and dissociation. Anxiety disorders do not include these trauma-specific cognitive features.
Treatment specificity: PTSD responds robustly to trauma-focused CBT (Prolonged Exposure, Cognitive Processing Therapy), EMDR, and SSRIs at standard doses. Anxiety treatments that work for generalized anxiety (pure worry-focused CBT, certain SSRIs at lower doses) are insufficient for PTSD.

The DSM-5 Trauma and Stressor-Related Disorders chapter includes:

Acute Stress Disorder (308.3) [symptoms 3 days to 1 month post-trauma]
PTSD (309.81) [symptoms > 1 month post-trauma]
Adjustment Disorders (309.x) [stressor is less severe; symptoms within 3 months of stressor onset]
Other specified trauma- and stressor-related disorder

Each shares a trauma or significant stressor but differs in timing, severity, and functional impairment.

PTSD DSM-5 diagnostic criteria (309.81) summarized

PTSD is defined by eight diagnostic criteria (A through H):

Criterion A: Trauma exposure

Exposure to actual or threatened death, serious injury, or sexual violence in one or more of the following ways:

Direct experience of trauma
Witnessing the trauma in person
Learning of the trauma happening to a close family member or friend (in violent or accidental circumstances)
Repeated or extreme indirect exposure to traumatic details (e.g., first responders, emergency room staff)

Critical: Not all exposures are equal. Natural disasters, car accidents, or medical procedures (if not life-threatening) may not meet Criterion A; interpersonal violence (assault, abuse, sexual assault), combat, serious motor vehicle accidents, and life-threatening illness typically do.

Criterion B: Intrusive memories

One or more intrusive symptoms:

Recurrent involuntary, unwanted memories of the trauma
Recurrent, distressing dreams related to the trauma
Flashbacks (acting as if the event is happening again; dissociative reactions)
Intense psychological distress when exposed to reminders
Marked physiological reactions to reminders (panic, hyperventilation)

Criterion C: Avoidance

Persistent avoidance of stimuli associated with the trauma:

Avoidance of thoughts, feelings, or conversations about the trauma
Avoidance of reminders (places, people, objects, activities, news items)

Criterion D: Negative alterations in mood and cognition

Two or more symptoms, present since trauma:

Inability to remember an important aspect of the trauma
Persistent, exaggerated negative beliefs about oneself, others, or the world ("No one can be trusted," "The world is entirely dangerous")
Persistent, distorted blame of self or others for the trauma
Persistent negative emotions (fear, anger, guilt, shame)
Markedly diminished interest or participation in activities
Feeling detached or estranged from others
Persistent inability to experience positive emotions (joy, love, satisfaction)

Criterion E: Alterations in arousal and reactivity

Two or more symptoms, present since trauma:

Irritability or aggression (verbal or physical)
Reckless or self-destructive behavior
Hypervigilance
Exaggerated startle response
Difficulty concentrating
Sleep disturbance (nightmares, insomnia)

Criterion F: Duration

Symptoms present for more than one month (distinguishes from Acute Stress Disorder, which is 3 days to 1 month).

Criterion G: Functional impairment

Clinically significant distress or impairment in social, occupational, or other important areas of functioning.

Criterion H: Exclusion

Symptoms are not due to substance use, medication, or a medical condition.

Symptom overlap with anxiety disorders

PTSD and anxiety disorders share some symptoms, which can cause confusion:

Hyperarousal: Both feature increased physiological reactivity, startle responses, sleep disturbance, irritability.
Avoidance: Both involve avoidance of feared situations or triggers.
Worry: PTSD often involves worry about symptom triggers or safety; anxiety disorders involve worry about various life domains (health, finances, social judgment).
Panic symptoms: Some PTSD patients experience panic-like symptoms when exposed to trauma reminders; panic disorder features spontaneous panic attacks without specific trauma cues.

However, PTSD has trauma-specific features anxiety disorders lack:

Intrusive re-experiencing: Flashbacks, nightmares, involuntary memories specific to the trauma. Anxiety disorder worries are future-oriented; PTSD intrusions are past-oriented.
Negative mood and cognitive changes: Persistent negative beliefs about self/world, emotional numbing, dissociation. These are not core anxiety disorder features.
Trauma Criterion A requirement: Anxiety disorders do not require trauma exposure.

Prevalence and comorbidity

Lifetime PTSD prevalence

The National Comorbidity Survey-Replication (NCS-R), conducted by Kessler and colleagues (2005), assessed the lifetime prevalence of PTSD in a nationally representative US sample.

Key finding: Approximately 6.8 percent of US adults experience PTSD in their lifetime.

Importantly, most people exposed to trauma do NOT develop PTSD. Estimates suggest 50-60 percent of people experience at least one traumatic event in their lifetime, but only a fraction develop PTSD. Risk factors include peritraumatic dissociation, lack of social support, prior trauma history, female sex, and ongoing life stress.

High comorbidity with anxiety disorders

Among people with PTSD, comorbidity rates are very high:

Approximately 50 percent have comorbid anxiety disorders (primarily generalized anxiety, panic disorder, social anxiety).
Approximately 50-70 percent have comorbid major depressive disorder.
Approximately 20-30 percent have comorbid substance use disorder (often self-medication for PTSD symptoms).

This overlap reflects shared genetic vulnerability, overlapping neurobiological circuits (amygdala, prefrontal cortex), and bidirectional worsening (untreated PTSD increases depression and anxiety risk; untreated anxiety worsens PTSD).

Not all traumatic events lead to PTSD

This is critical: Most people recover after a traumatic event without developing PTSD.

Longitudinal research shows:

Normal recovery trajectory: Most trauma survivors show natural symptom improvement over the first 3-6 months post-trauma.
Minority develop PTSD: Approximately 20-30 percent develop PTSD that persists beyond one month.
Risk factors for PTSD development:
Peritraumatic dissociation (feeling detached during or immediately after trauma)
Lack of social support
Prior trauma history (especially childhood trauma)
Female sex (women are 2x more likely than men to develop PTSD)
Ongoing life stress concurrent with trauma
Personality factors (higher neuroticism, lower conscientiousness)

Clinical implication: Early screening after trauma is important. If symptoms persist beyond one month, professional help is warranted. However, not all early post-trauma distress indicates PTSD; natural recovery is the norm.

Complex PTSD and dissociative presentations

Complex PTSD (C-PTSD)

The ICD-11 (World Health Organization's International Classification of Diseases) introduced the diagnosis "Complex PTSD" (code 6B41), distinct from PTSD.

C-PTSD arises from prolonged, repeated trauma, typically:

Childhood abuse (physical, emotional, sexual)
Domestic violence
Captivity, trafficking, war
Medical trauma (repeated procedures, chronic illness)

Additional features beyond PTSD:

Affect dysregulation (difficulty controlling emotions)
Negative self-perception ("I am broken," "I am worthless")
Disturbances in relationships (difficulty trusting, difficulty maintaining connections)
Dissociative symptoms (persistent, pervasive dissociation)

Note: DSM-5 does not use the C-PTSD label. Instead, DSM-5 recognizes a "Dissociative Subtype of PTSD" for individuals with high dissociative symptoms. However, van der Kolk's clinical research emphasizes that early childhood trauma produces a qualitatively different presentation requiring specialized trauma treatment.

PTSD vs. specific anxiety disorders: key differentiation

PTSD vs. Panic Disorder

Feature · Panic Disorder · PTSD

Triggering event · No specific trauma required · Requires exposure to trauma (Criterion A)

Panic attack pattern · Spontaneous or unexpected; not tied to specific cues · Panic-like symptoms triggered by trauma reminders

Core feature · Panic attacks + anticipatory anxiety · Intrusive re-experiencing + avoidance + negative cognition/mood

Thought content · Fear of panic itself ("I'm going to have another attack") · Re-experiencing trauma memory, negative beliefs about world/self

Treatment focus · CBT for anxiety, breathing retraining, exposure to bodily sensations · Trauma-focused CBT (PE, CPT), trauma processing

PTSD vs. Generalized Anxiety Disorder (GAD)

Feature · GAD · PTSD

Worry content · Future-oriented worry (finances, health, relationships, job) · Past-oriented intrusive memories and flashbacks

Trigger · Generalized uncertainty and worry; no specific trauma required · Specific trauma exposure; triggered by reminders

Avoidance · Behavioral avoidance (avoiding situations that trigger worry) · Avoidance of trauma-related triggers

Negative cognitions · Worry about "what if" scenarios · Negative beliefs about self and world, blame, shame

Treatment · Worry-focused CBT, acceptance-based approaches, SSRIs at standard doses · Trauma-focused CBT (PE, CPT, EMDR), SSRIs at standard doses

PTSD vs. Specific Phobia

Feature · Specific Phobia · PTSD

Fear focus · Specific object or situation (dogs, heights, flying, needles) · Trauma-related reminders (variable content)

Trauma requirement · No trauma required (often develops through modeling or preparedness) · Requires trauma exposure (Criterion A)

Intrusions · Minimal; primarily anxiety when facing phobic object · Recurrent intrusive memories, flashbacks, nightmares

Avoidance · Avoidance of phobic object · Avoidance of trauma-related situations, people, thoughts

Treatment · Exposure-based (simple, systematic desensitization) · Trauma-focused CBT (more complex, requires processing)

PTSD vs. Social Anxiety Disorder

Feature · Social Anxiety · PTSD

Fear focus · Social evaluation, embarrassment, judgment · Trauma-related memories and reminders

Trigger · Social situations, performance · Reminders of trauma

Avoidance · Avoidance of social situations · Avoidance of trauma-related cues

Intrusions · Worry about future social situations · Involuntary re-experiencing of past trauma

Treatment · Social skills training, cognitive restructuring, exposure · Trauma-focused CBT, trauma processing

PTSD vs. OCD

Feature · OCD · PTSD

Obsessions · Unwanted, ego-dystonic thoughts (contamination, harm) · Trauma memories, flashbacks (unwanted but trauma-related)

Compulsions · Ritualistic behaviors or mental acts (cleaning, checking, counting) · Avoidance behaviors (not ritualistic compulsions)

Trigger · Internal thoughts (not necessarily external trauma) · External trauma memory or reminder

Treatment focus · Exposure and Response Prevention (ERP) · Trauma-focused CBT (PE, CPT, EMDR)

Medication · Higher SSRI doses (fluoxetine 60-80 mg, sertraline 200 mg) · Standard SSRI doses (sertraline 50-200 mg, paroxetine 20-40 mg)

Evidence-based first-line psychotherapies for PTSD

Prolonged Exposure (PE)

PE is one of the two gold-standard psychotherapies for PTSD, developed and extensively researched by Dr. Edna Foa.

How PE works:

Psychoeducation: Explain PTSD, avoidance cycle, and rationale for exposure.
Imaginal exposure: Patient narrates the trauma memory repeatedly in session (15-20 minutes), processing the traumatic content and emotions.
In-vivo exposure: Graduated, repeated exposure to trauma-related reminders in real-world settings (safe situations the person has been avoiding).
Habituation: With repeated exposure without avoidance, anxiety naturally decreases; the brain learns the trauma reminder is not currently dangerous.

Evidence: Foa's landmark randomized controlled trials demonstrated PE superior to supportive counseling and equivalent to sertraline + PE. The International Society for the Study of Trauma and Stress (ISTSS) rates PE as "strongly recommended."

Duration: Typically 8-15 sessions of 90 minutes (longer than standard CBT) over 2-3 months.

Considerations: Intensive and emotionally demanding; not suitable for all patients (those with active suicidality, severe substance use, or untreated dissociation may need preparation first).

Cognitive Processing Therapy (CPT)

CPT is the second gold-standard psychotherapy, developed by Dr. Patricia Resick, specifically targeting trauma-related cognitions.

How CPT works:

Cognitive assessment: Identify unhelpful trauma-related beliefs ("The world is entirely unsafe," "I'm worthless").
Trauma account: Write a detailed account of the trauma (imaginal processing).
Cognitive processing: Challenge and modify trauma-related beliefs using structured worksheets.
Impact statement: Write about the impact of the trauma and how beliefs have changed.

Key focus: CPT emphasizes that PTSD is maintained by maladaptive trauma-related cognitions; changing these beliefs (with or without the person consciously re-experiencing the trauma memory) reduces symptoms.

Evidence: CPT has strong efficacy in multiple RCTs, with effect sizes comparable to PE. It's particularly useful when trauma-related guilt, shame, or responsibility are prominent.

Duration: 12 sessions typically, twice weekly.

Advantages over PE: Less emotionally intense reliving of trauma; more structured cognitive work.

Eye Movement Desensitization and Reprocessing (EMDR)

EMDR is an established treatment, developed by Dr. Francine Shapiro, with strong evidence and WHO endorsement.

How EMDR works:

Trauma target selection: Identify a specific trauma memory, associated emotions, beliefs, and physical sensations.
Bilateral stimulation: While recalling the trauma, the patient engages in rapid eye movements (following therapist's finger), tapping, or auditory stimulation.
Processing: The bilateral stimulation, combined with trauma recall, facilitates emotional processing and cognitive integration.
Reprocessing: Repeated cycles desensitize the emotional charge of the memory and integrate adaptive beliefs.

Mechanism: The exact mechanism is debated. Theories include: bilateral stimulation mimics REM sleep (when emotional memories consolidate and threat perception diminishes), reduces working memory load (allowing the brain to process the memory differently), or activates brain regions involved in emotional regulation.

Evidence: EMDR has strong evidence for PTSD reduction (effect sizes 1.2-2.0). The American Psychiatric Association, International Society for PTSD Studies (ISTSS), and World Health Organization (WHO) recommend EMDR as first-line.

Duration: Typically 6-12 sessions, often faster symptom reduction than PE/CPT.

Advantages: Less verbalization required; can be helpful for trauma survivors with dissociation or difficulty articulating trauma narratives.

Trauma-focused Cognitive Behavioral Therapy (TF-CBT)

TF-CBT is a manualized treatment, especially validated for children and adolescents, adaptable for adults.

Components: Psychoeducation, parenting skills, relaxation, affect regulation, cognitive coping, imaginal exposure, in-vivo exposure, cognitive processing, relapse prevention.

Evidence: ISTSS rates TF-CBT "strongly recommended" for children; also used in adults.

Cognitive Therapy for PTSD (CT-PTSD)

Developed by Ehlers and Clark, this approach emphasizes trauma-related cognitive processes (e.g., thought-action fusion, overgeneralization of threat).

Evidence: Multiple RCTs support efficacy; particularly effective when trauma-related beliefs and self-blame are prominent.

Evidence-based medications for PTSD

FDA-approved SSRIs

Sertraline (Zoloft) and Paroxetine (Paxil) are the only SSRIs with FDA approval for PTSD.

Sertraline: Starting 50 mg daily, titrate to 50-200 mg daily (typical effective dose 50-150 mg). Often well-tolerated.
Paroxetine: Starting 10-20 mg daily, titrate to 20-40 mg daily (typical effective dose 40 mg). Higher starting dose (10-20 mg) than sertraline.

Efficacy: Both show moderate effect sizes (d = 0.4-0.6) in reducing PTSD symptom severity. Combined with trauma-focused psychotherapy, response is stronger.

Time to response: Allow 6-8 weeks at full dose for initial improvement; 12 weeks for full benefit.

Other evidence-based SSRIs (off-label)

Fluoxetine: 20-80 mg daily. Evidence available; some studies show benefit.
Fluvoxamine: 100-300 mg daily. Limited PTSD data but used in practice.

SNRI: Venlafaxine (Effexor)

Dose: 75-375 mg daily (extended-release formulation preferred).
Evidence: Strong evidence for PTSD symptom reduction; effect size comparable to SSRIs.
Advantage: May be particularly helpful if depression is prominent.

Prazosin for nightmares

Drug: Alpha-1-adrenergic antagonist (typically used for hypertension).
FDA approval: FDA-approved for PTSD-related nightmares.
Dose: 1-20 mg at bedtime (titrate gradually).
Efficacy: Reduces nightmare frequency and severity, improves sleep; some benefit for hyperarousal.
Use case: Often added to SSRIs if nightmares are severely disabling.

Benzodiazepines: AVOID in PTSD

Critical: Benzodiazepines (alprazolam, clonazepam, lorazepam) are NOT recommended for PTSD.

Why avoid:

Interfere with extinction learning: Prevent the brain from learning that trauma reminders are safe.
Worsen long-term outcomes: Benzodiazepine use correlates with worse PTSD trajectory.
Abuse and dependence risk: High addiction potential, especially in trauma survivors.
VA/DoD guideline**: The 2023 VA/DoD Clinical Practice Guideline for PTSD explicitly advises against benzodiazepines as first-line.

Exception: Brief, acute use (a few days) immediately after trauma may be acceptable; chronic use is not.

Emerging treatments

MDMA-assisted therapy: Pilot and Phase 3 trials show remarkable efficacy (PTSD remission rates 60-70 percent). FDA breakthrough therapy designation granted. FDA review ongoing.
Ketamine and esketamine: Rapid-acting antidepressants; exploratory research for PTSD. Not yet standard treatment.

Complementary and supportive strategies

Beyond first-line psychotherapy and medication:

Mindfulness-based stress reduction (MBSR): Evidence for anxiety and PTSD symptom reduction.
Yoga and somatic therapies: van der Kolk's research emphasizes body-based trauma processing; yoga, dance, and somatic experiencing can help restore sense of safety.
Physical exercise: Regular aerobic exercise reduces anxiety and depression in PTSD.
Social support: Strong protective factor; peer support groups, veterans groups, RAINN support communities reduce isolation.
Sleep hygiene: Insomnia compounds PTSD; sleep medication (prazosin, trazodone) or CBT-I (cognitive-behavioral therapy for insomnia) often necessary.
Substance use treatment: If comorbid, address substance use concurrently with PTSD treatment.

When anxiety is PTSD in disguise

Critically: People often seek help for "anxiety" when the underlying diagnosis is PTSD.

A person may report "anxiety attacks," "panic," "constant worry," or "social avoidance" without spontaneously mentioning trauma. The trauma may be normalized (childhood abuse, military service, sexual assault) or excluded due to shame, dissociation, or therapeutic avoidance.

Screening for PTSD in anxiety workup:

Ask directly: "Have you experienced or witnessed a traumatic event (threat to life, serious injury, sexual violence, combat, serious accident, assault, abuse)?"
Use PTSD screens: PCL-5 (17-item self-report), PDS (Posttraumatic Diagnostic Scale).
Assess trauma-specific symptoms: flashbacks, intrusive memories, nightmares, avoidance of trauma reminders.
Assess negative mood/cognition changes: persistent negative beliefs about self/world, emotional numbing, dissociation.

Implication: Inadequate "anxiety treatment" often reflects undiagnosed PTSD. A person with PTSD receiving pure worry-focused CBT or benzodiazepines will not improve; trauma-focused treatment is essential.

When to seek professional help

Seek mental health evaluation if, after a traumatic event, you experience:

Persistent intrusive memories, flashbacks, or nightmares (weeks to months after trauma)
Avoidance of reminders (places, people, activities related to trauma)
Persistent negative beliefs about yourself or the world
Emotional numbing or dissociation (feeling disconnected from others or yourself)
Hyperarousal symptoms: hypervigilance, exaggerated startle, sleep disturbance, irritability, difficulty concentrating
Functional impairment: difficulty working, maintaining relationships, or performing daily tasks
Duration > 1 month post-trauma

Early intervention: Seeking help sooner rather than later improves outcomes. Brief early psychoeducation and support within the first month post-trauma can prevent PTSD chronicity.

Specialized trauma therapists: Seek therapists trained in PE, CPT, EMDR, or TF-CBT. General therapists untrained in trauma may inadvertently reinforce avoidance.

FAQ: PTSD and Anxiety

1. Is PTSD classified as an anxiety disorder?

No. In the DSM-5 (2013), PTSD was reclassified from Anxiety Disorders into its own chapter: "Trauma and Stressor-Related Disorders." While PTSD shares some features with anxiety (avoidance, hyperarousal), it has distinct diagnostic criteria (trauma exposure requirement, intrusive re-experiencing, negative mood/cognitive alterations) and treatment needs. Think of PTSD as a trauma disorder with anxiety-like features, not an anxiety disorder.

2. What's the difference between PTSD and panic disorder?

PTSD requires exposure to a specific trauma; panic disorder does not. In panic disorder, panic attacks are spontaneous or triggered by internal cues (heart racing, dizziness). In PTSD, panic-like symptoms are triggered by reminders of the trauma. PTSD's core is re-experiencing the trauma memory through flashbacks, nightmares, and intrusive thoughts. Panic disorder's core is fear of panic attacks themselves. Treatment differs: panic disorder uses cognitive-behavioral therapy for anxiety and breathing retraining; PTSD uses trauma-focused CBT (PE, CPT, EMDR).

3. Can you have PTSD without a formally diagnosed trauma?

PTSD requires Criterion A: exposure to actual or threatened death, serious injury, or sexual violence. This includes events not formally "diagnosed" but that meet the criteria. Examples: witnessing a severe car accident, experiencing or witnessing violence, sexual assault (whether reported or not), military combat, life-threatening medical procedures, childhood abuse. If you're unsure, a trauma-informed therapist can help assess. Many trauma survivors minimize their experiences or don't label them as "traumatic," yet still meet PTSD criteria.

4. Do I have to talk about the trauma in therapy to recover?

Many trauma-focused treatments involve narrating or processing the trauma (Prolonged Exposure, Cognitive Processing Therapy). However, EMDR and some trauma therapies allow processing with less explicit narration. The key is engaging with the trauma memory (not continuing to avoid it) so the brain can reprocess it. A trauma-informed therapist will help you tolerate this at a pace that feels safe. Avoidance maintains PTSD; some engagement (guided by a skilled therapist) is necessary for recovery.

5. Is EMDR effective for PTSD?

Yes. EMDR is strongly recommended by the American Psychiatric Association, ISTSS (International Society for the Study of Trauma and Stress), and the WHO. Randomized controlled trials show large effect sizes (symptom reduction comparable to PE and CPT). The mechanism (why bilateral stimulation helps) is not fully understood, but efficacy is established. EMDR may be faster than PE/CPT for some patients (6-12 weeks vs. 12-15 weeks). Choose a therapist specifically trained and certified in EMDR protocol.

6. What medications treat PTSD?

FDA-approved SSRIs: sertraline (Zoloft) and paroxetine (Paxil). Other evidence-based options: fluoxetine (Prozac), venlafaxine (Effexor, an SNRI). Prazosin (Minipress) is FDA-approved for PTSD-related nightmares. Benzodiazepines should be avoided; they impair long-term recovery. Medication typically takes 6-8 weeks to show benefit and works best combined with trauma-focused psychotherapy.

7. Can PTSD be cured?

PTSD can be effectively treated so that symptoms significantly decrease or remit entirely. "Cure" is not standard terminology; more accurate: "recovery," "remission," or "significant improvement." Many people achieve substantial recovery with trauma-focused psychotherapy (PE, CPT, EMDR), especially if treatment is started early. Some symptoms may persist at low levels (e.g., startle response), but functioning and quality of life improve markedly. Earlier intervention and consistent treatment increase chances of full recovery.

8. What is complex PTSD?

Complex PTSD (C-PTSD) arises from prolonged, repeated trauma (childhood abuse, trafficking, domestic violence, war). Beyond PTSD symptoms, C-PTSD includes difficulty regulating emotions, persistent negative self-perception ("I am broken"), relationship difficulties (trust issues), and dissociation. The ICD-11 (WHO) includes C-PTSD as a distinct diagnosis. The DSM-5 does not use "C-PTSD" but recognizes a dissociative subtype of PTSD. Treatment is similar (trauma-focused CBT, medication) but may require longer duration and trauma-sensitive approaches addressing dissociation and attachment.

Crisis resources

If you or someone you know is in crisis or having thoughts of self-harm, help is available 24/7:

988 Suicide and Crisis Lifeline: Call or text 988 (US)
Veterans Crisis Line: Call 988 and press 1, or text 838255
Crisis Text Line: Text HOME to 741741
RAINN National Sexual Assault Hotline: 1-800-656-HOPE (4673), available 24/7 for sexual assault survivors
National Domestic Violence Hotline: 1-800-799-7233 (1-800-799-SAFE), 24/7
International Association for Suicide Prevention: https://www.iasp.info/resources/Crisis_Centres/ (global resources)
SAMHSA National Helpline: 1-800-662-4357, free and confidential, 24/7
Text HOME to 741741 for immediate crisis support via Crisis Text Line

Tier-1 sources and references

Diagnostic manuals and guidelines

DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition): American Psychiatric Association (2013). Code 309.81 for PTSD, chapter "Trauma and Stressor-Related Disorders."
ICD-11 (International Classification of Diseases, 11th Revision): World Health Organization (2019). Code 6B40 for PTSD, code 6B41 for Complex PTSD.
VA/DoD Clinical Practice Guideline for PTSD: U.S. Department of Veterans Affairs & Department of Defense (2023). Comprehensive evidence-based recommendations for assessment and treatment.
APA Practice Guideline for the Treatment of PTSD: American Psychological Association (2017). Evidence-based guidelines for psychotherapy and pharmacotherapy.

Epidemiology and comorbidity

Kessler RC, et al. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593-602. [NCS-R study; 6.8% PTSD lifetime prevalence]

Psychotherapy evidence

Foa EB, et al. (2005). Efficacy of prolonged exposure therapy in PTSD. Key foundational RCT demonstrating PE superiority.
Resick PA, et al. (2016). Cognitive Processing Therapy for PTSD: A Comprehensive Manual. Oxford University Press. [CPT manual and evidence]
Shapiro F. (2001). Eye Movement Desensitization and Reprocessing (EMDR): Basic Principles, Protocols, and Procedures. 2nd ed., Guilford Press.
Bradley R, Greene J, Russ E, Dutra L, & Westen D. (2005). A multidimensional meta-analysis of psychotherapy for PTSD. American Journal of Psychiatry, 162(2), 214-227. [Meta-analysis of trauma-focused psychotherapy efficacy]

Neurobiology and trauma

van der Kolk BA. (2014). The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. Viking. [Accessible synthesis of trauma neurobiology and somatic therapies]
Pitman RK, Rasmusson AM, Koenen KC, et al. (2012). Biological studies on post-traumatic stress disorder. Nature Reviews Neuroscience, 13(11), 769-787.

Clinical resources

ISTSS (International Society for the Study of Trauma and Stress): Publishes treatment guidelines and PTSD practice parameters.
National Institute of Mental Health (NIMH): https://www.nimh.nih.gov (PTSD overview, research updates)
National Center for PTSD (VA): https://www.ptsd.va.gov (clinician resources, screening tools, patient education)
Mayo Clinic, Cleveland Clinic, NHS (UK): Evidence-based patient education on PTSD.